Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples